一种可作为治疗冠心病的辅助药物——果糖磷酸钠,由海军医学研究所科研人员研制成功,日前通过了国家卫生部的审批,获得二类新药证书。 果糖磷酸钠是国外七十年代开发研制的一种新药,它能调节人体内葡萄糖代谢中许多酶的活性,增强细胞内高能磷酸键 One can be used as an adjunctive drug for the treatment of coronary heart disease - fructose sodium phosphate, developed by the Naval Medical Research Institute researchers successfully passed the approval of the State Ministry of Health, access to two types of new drug certificate. Fructose sodium phosphate is developed abroad in the seventies a new drug, it can regulate the human body glucose metabolism in many enzyme activity, increased intracellular high-energy phosphate bond